Get the tools used by (smart)² investors.

SP500 -0.3%DOW -0.1%FTSE 100 -0.0%NIKKEI -0.2%OIL 1.8%GOLD -0.1%

Watchlists Ideas Screener Data Explorer Charts Saved Work

Net Debt / Total Capital for Insulet Corporation

Join now and get access to the full platform

Search for company or ETF

0 results available. Select is focused ,type to refine list, press Down to open the menu,

PODD: Insulet Corporation

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform ...

265.39 USD

Price

– USD

Fair Value

–

Upside

160.19 - 289.46

52-week range

Create Chart Create Model Add To Watchlist

Analysis

Fiscal Years

Trailing Twelve Months

Fiscal Halfs

Fiscal Quarters

Daily

Hide this widget

The following section summarizes insights on Insulet Corporation's Net Debt / Total Capital:

Performance Summary

Insulet's latest twelve months net debt / total capital is 2.4%
Insulet's net debt / total capital for fiscal years ending December 2020 to 2024 averaged 2.5%.
Insulet's operated at median net debt / total capital of 2.4% from fiscal years ending December 2020 to 2024.
Looking back at the last 5 years, Insulet's net debt / total capital peaked in December 2023 at 4.6%.
Insulet's net debt / total capital hit its 5-year low in December 2020 of 0.2%.
Insulet's net debt / total capital decreased in 2020 (0.2%, -95.1%) and 2024 (2.4%, -48.3%) and increased in 2021 (2.2%, +1,220.6%), 2022 (3.1%, +43.5%), and 2023 (4.6%, +47.7%).

Benchmarks

Metric Usage: Net Debt / Total Capital

Hide this widget

net_debt_to_capital

Slug

number

Datatype

text

Format

current

Default Period

FY, LTM

Periods Supported

Free

Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Net Debt / Total Capital in the risk category include:

Total Debt / EBITDA - A ratio that is calculated as Total Debt (including Capital Leases) divided by EBITDA.
Cash And ST Investments / Total Assets - A ratio that measures a company's cash and short-term investments as a percentage of total assets.
EBITDA less CapEx Interest Coverage Ratio - A ratio used to assess a firm's ability to pay interest expenses based on EBITDA less Capital Expenditures.
Sloan Ratio - A formula developed by Richard Sloan in 1996 that measures the degree of accruals versus reported earnings.

View Full List

Search for metric or datapoint

Net Debt / Total Capital

A ratio that measures the level of the net debt relative to the market value of total capital. Net debt is the sum of all long term debt fields minus ...

Definition of Net Debt / Total Capital

Hide this widget

A ratio that measures the level of the net debt relative to the market value of total capital. Net debt is the sum of all long term debt fields minus cash and short-term investments.

Sector Benchmark Analysis

Sector

Industry Group

Industry

Hide this widget

The chart above depicts the distribution of net debt / total capital for companies operating in the Healthcare sector in the Developed economic region. Over 2,460 companies were considered in this analysis, and 2,363 had meaningful values. The average net debt / total capital of companies in the sector is -11.9% with a standard deviation of 50.9%.

Insulet Corporation's Net Debt / Total Capital of 2.4% ranks in the 61.9% percentile for the sector. The following table provides additional summary stats:

Net Debt / Total Capital In The Healthcare Sector
Economic Risk Region	Developed
Total Constituents	2,461
Included Constituents	2,363
Min	-229.6%
Max	89.2%
Median	-3.1%
Mean	-11.9%
Standard Deviation	50.9%

You can find companies with similar net debt / total capital using this stock screener.